Susan Rodriguez - 30 Jan 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Kathryn Lester Attorney-in-fact for Susan Rodriguez
Issuer symbol
HRTX
Transactions as of
30 Jan 2025
Net transactions value
+$62,107
Form type
4
Filing time
03 Feb 2025, 11:33:51 UTC
Previous filing
20 Jun 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +17,950 +26% $0.000000 87,180 30 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $62,107 +35,900 $1.73 35,900 30 Jan 2025 Common Stock 35,900 $1.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.